Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

NCT05860465 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Breast Cancer

Interventions

DRUG: SPH4336 Tablets
DRUG: SPH4336 Tablets Placebo

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd